Old Web
English
Sign In
Acemap
>
authorDetail
>
Timothy P Hughes
Timothy P Hughes
Oregon Health & Science University
Imatinib
Gastroenterology
Immunology
Medicine
Internal medicine
3
Papers
196
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations
2008
Blood
Martin C. Müller
Jorge Cortes
Dong-Wook Kim
Brian J. Druker
Philipp Erben
Ricardo Pasquini
Timothy P Hughes
Yousif Matloub
Lynn Ploughman
A. Hochhaus
Show All
Source
Cite
Save
Citations (17)
International Randomized Study of Interferon Versus STI571 (IRIS) 7-Year Follow-up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CMLCP) Treated with Imatinib (IM)
2008
Blood
Stephen G. O’Brien
F. Guilhot
John M. Goldman
A. Hochhaus
Timothy P Hughes
Jerald P. Radich
Marc Rudoltz
Jeiry Filian
Insa Gathmann
Brian J. Druker
R. A. Larson
Show All
Source
Cite
Save
Citations (166)
Imatinib (IM) Pharmacokinetic (PK) Exposure and Its Correlation with Clinical Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) for 400 Mg and 800 Mg Daily Doses (Tyrosine Kinase Dose Optimization Study [TOPS])
2008
Blood
F. Guilhot
Timothy P Hughes
Jorge E. Cortes
Yanfeng Wang
Michael Hayes
Anthony Gichangi
Brian J. Druker
Michele Baccarani
Show All
Source
Cite
Save
Citations (13)
1